Ceric Sàrl
Clinical trials sponsored by Ceric Sàrl, explained in plain language.
-
Clot-Busting catheter may limit heart attack damage in major trial
Disease control Recruiting nowThis study tests whether using a special suction device (INDIGO ASPIRATION SYSTEM with CAT RX) to remove blood clots during emergency heart artery opening (angioplasty) can reduce heart muscle damage compared to standard angioplasty alone. About 140 adults with a severe type of h…
Phase: NA • Sponsor: Ceric Sàrl • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Heart artery showdown: which 'Leave nothing Behind' strategy wins for young patients?
Disease control Recruiting nowThis study looks at two ways to open blocked heart arteries in people aged 18 to 68. One uses a drug-coated balloon, and the other uses a temporary scaffold. The goal is to see which approach works better over 5 years. About 2,256 participants will be followed with phone calls an…
Phase: NA • Sponsor: Ceric Sàrl • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New heart valve procedure could rival surgery for seniors with stiff aortic valve
Disease control Recruiting nowThis study compares a new, less invasive balloon-expandable heart valve (Myval) with traditional open-heart surgery in 1,180 patients aged 65 to 75 who have severe aortic stenosis (a narrowed heart valve). The goal is to see if the less invasive option is as safe and effective as…
Phase: NA • Sponsor: Ceric Sàrl • Aim: Disease control
Last updated May 20, 2026 11:57 UTC